Manjula Kurella Tamura1,2, I-Chun Thomas1,2, Maria E Montez-Rath2, Kristopher Kapphahn3, Manisha Desai3, Randall C Gale4,5, Steven M Asch4,5. 1. Geriatric Research and Education Clinical Center, Veterans Affairs Palo Alto Health Care System, Palo Alto, California. 2. Division of Nephrology, Stanford University School of Medicine, Palo Alto, California. 3. Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, California. 4. Center for Innovation to Implementation, Veterans Affairs Palo Alto Health Care System, Palo Alto, California. 5. Division of General Medicine, Stanford School of Medicine, Palo Alto, California.
Abstract
Importance: The benefits of maintenance dialysis for older adults with end-stage renal disease (ESRD) are uncertain. Whether the setting of pre-ESRD nephrology care influences initiation of dialysis and mortality is not known. Objective: To compare initiation of dialysis and mortality among older veterans with incident kidney failure who received pre-ESRD nephrology care in fee-for-service Medicare vs the Department of Veterans Affairs (VA). Design, Setting, and Participants: Retrospective cohort study of patients from the US Medicare and VA health care systems evaluated 11 215 veterans aged 67 years or older with incident kidney failure between January 1, 2008, and December 31, 2011. Data analysis was performed March 15, 2016, through September 20, 2017. Exposures: Pre-ESRD nephrology care in Medicare vs VA health care systems. Main Outcome and Measures: Dialysis treatment and death within 2 years. Results: Of the 11 215 patients included in the study, 11 085 (98.8%) were men; mean (SD) age was 79.1 (6.9) years. Within 2 years of incident kidney failure, 7071 (63.0%) of the patients started dialysis and 5280 (47.1%) died. Patients who received pre-ESRD nephrology care in Medicare were more likely to undergo dialysis compared with patients who received pre-ESRD nephrology care in VA (82% vs 53%; adjusted risk difference, 28 percentage points; 95% CI, 26-30 percentage points). Differences in dialysis initiation between Medicare and VA were more pronounced among patients aged 80 years or older and patients with dementia or metastatic cancer, and less pronounced among patients with paralysis (P < .05 for interaction). Two-year mortality was higher for patients who received pre-ESRD care in Medicare compared with VA (53% vs 44%; adjusted risk difference, 5 percentage points; 95% CI, 3-7 percentage points). The findings were similar in a propensity-matched analysis. Conclusions and Relevance: Veterans who receive pre-ESRD nephrology care in Medicare receive dialysis more often yet are also more likely to die within 2 years compared with those in VA. The VA's integrated health care system and financing appear to favor lower-intensity treatment for kidney failure in older patients without a concomitant increase in mortality.
Importance: The benefits of maintenance dialysis for older adults with end-stage renal disease (ESRD) are uncertain. Whether the setting of pre-ESRD nephrology care influences initiation of dialysis and mortality is not known. Objective: To compare initiation of dialysis and mortality among older veterans with incident kidney failure who received pre-ESRD nephrology care in fee-for-service Medicare vs the Department of Veterans Affairs (VA). Design, Setting, and Participants: Retrospective cohort study of patients from the US Medicare and VA health care systems evaluated 11 215 veterans aged 67 years or older with incident kidney failure between January 1, 2008, and December 31, 2011. Data analysis was performed March 15, 2016, through September 20, 2017. Exposures: Pre-ESRD nephrology care in Medicare vs VA health care systems. Main Outcome and Measures: Dialysis treatment and death within 2 years. Results: Of the 11 215 patients included in the study, 11 085 (98.8%) were men; mean (SD) age was 79.1 (6.9) years. Within 2 years of incident kidney failure, 7071 (63.0%) of the patients started dialysis and 5280 (47.1%) died. Patients who received pre-ESRD nephrology care in Medicare were more likely to undergo dialysis compared with patients who received pre-ESRD nephrology care in VA (82% vs 53%; adjusted risk difference, 28 percentage points; 95% CI, 26-30 percentage points). Differences in dialysis initiation between Medicare and VA were more pronounced among patients aged 80 years or older and patients with dementia or metastatic cancer, and less pronounced among patients with paralysis (P < .05 for interaction). Two-year mortality was higher for patients who received pre-ESRD care in Medicare compared with VA (53% vs 44%; adjusted risk difference, 5 percentage points; 95% CI, 3-7 percentage points). The findings were similar in a propensity-matched analysis. Conclusions and Relevance: Veterans who receive pre-ESRD nephrology care in Medicare receive dialysis more often yet are also more likely to die within 2 years compared with those in VA. The VA's integrated health care system and financing appear to favor lower-intensity treatment for kidney failure in older patients without a concomitant increase in mortality.
Authors: Amber E Barnato; M Brooke Herndon; Denise L Anthony; Patricia M Gallagher; Jonathan S Skinner; Julie P W Bynum; Elliott S Fisher Journal: Med Care Date: 2007-05 Impact factor: 2.983
Authors: Ron Wald; Robert R Quinn; Jin Luo; Ping Li; Damon C Scales; Muhammad M Mamdani; Joel G Ray Journal: JAMA Date: 2009-09-16 Impact factor: 56.272
Authors: Manjula Kurella Tamura; Kenneth E Covinsky; Glenn M Chertow; Kristine Yaffe; C Seth Landefeld; Charles E McCulloch Journal: N Engl J Med Date: 2009-10-15 Impact factor: 91.245
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Virginia Wang; Cynthia J Coffman; Karen M Stechuchak; Theodore S Z Berkowitz; Paul L Hebert; David Edelman; Ann M O'Hare; Susan T Crowley; Hollis J Weidenbacher; Matthew L Maciejewski Journal: J Am Soc Nephrol Date: 2018-12-07 Impact factor: 10.121
Authors: Susan P Y Wong; Lynne V McFarland; Chuan-Fen Liu; Ryan J Laundry; Paul L Hebert; Ann M O'Hare Journal: JAMA Intern Med Date: 2019-03-01 Impact factor: 21.873
Authors: Catherine R Butler; Elizabeth K Vig; Ann M O'Hare; Chuan-Fen Liu; Paul L Hebert; Susan P Y Wong Journal: J Gen Intern Med Date: 2019-10-25 Impact factor: 5.128
Authors: Michael J Fischer; Elani Streja; Jui-Ting Hsiung; Susan T Crowley; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Wissam M Kourany Journal: Clin Kidney J Date: 2021-06-25
Authors: Chi-Yuan Hsu; Rishi V Parikh; Leonid N Pravoverov; Sijie Zheng; David V Glidden; Thida C Tan; Alan S Go Journal: JAMA Intern Med Date: 2020-12-01 Impact factor: 21.873
Authors: Emily K King; Ming-Han Hsieh; David R Chang; Cheng-Ting Lu; I-Wen Ting; Charles C N Wang; Pei-Shan Chen; Hung-Chieh Yeh; Hsiu-Yin Chiang; Chin-Chi Kuo Journal: Sci Rep Date: 2021-07-06 Impact factor: 4.379